Monitoring Adherence to Antihypertensive Drug Treatment by using a Dried Blood Spot test-test validatio

• Conditions: high blood pressure; Hypertension; 10057166

• Registration Number: NL-OMON46253
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 23 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Automated blood pressure measurement (datascope) or office blood pressure <135/85 mm Hg
Usage of at least one antihypertensive drug for which the DBS-test has been developed

Exclusion Criteria

Insufficient understanding of Dutch

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Agreement of plasma levels of eight hypertensive drugs when measured in DBS<br /><br>compared to plasma levels obtained by venipuncture</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Plasma concentrations of eight hypertensive drugs 1-4 hours after intake<br /><br>Trough levels of eight antihypertensive drugs</p><br>